Enteroendocrine cell reprogramming during intestinal injury
Enteroendocrine cell reprogramming during intestinal injury
批准号:
10438524
负责人:
Brian David Muegge
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-01 至 2025-01-31
关键词:
Academic skillsAchievementAddressAdoptedAdvisory CommitteesAirAnimal ModelAnimalsApplications GrantsAreaBiologyCell Culture SystemCell Culture TechniquesCell LineCell LineageCell NucleusCell physiologyCell secretionCellsCellular StressColonComputational BiologyComputer AnalysisComputing MethodologiesDataDevelopmentDevelopmental BiologyDiseaseDoctor of MedicineDoctor of PhilosophyEndocrineEndocrine systemEndocrinologyEnsureEnteroendocrine CellEpithelialFellowshipFoundationsFutureGLP-2Genetic TranscriptionGenomicsGoalsGoblet CellsGrantGrowthGrowth FactorHealth PrioritiesHealthcare SystemsHomeostasisHormone secretionHormonesIn VitroInflammatory Bowel DiseasesInjuryInternal MedicineIntestinal DiseasesIntestinesK-Series Research Career ProgramsKnock-outKnowledgeLaboratoriesLeadLiquid substanceMedical centerMentorsMetabolic DiseasesMetabolismMethodsModelingMolecularMonitorMucous MembraneOutcomeParacrine CommunicationPathway interactionsPatientsPatternPhenotypePhysiciansPopulationPrevalenceProductionPublishingRegulationResearchResidenciesResistanceResolutionSamplingScientistSerotoninSignal TransductionSomatostatinSourceStructureSystemTechniquesTechnologyTestingTrainingUniversitiesVeteransWashingtonWorkWritingbasecareercytokineendoplasmic reticulum stressepithelial injuryexperienceexperimental studyglucagon-like peptide 1healingin vitro Modelin vivoinjury and repairinsightintercellular communicationintestinal epitheliumintestinal injurymicrobialmonolayernew therapeutic targetnovelnovel strategiesprogenitorprogramsreceptorrepairedresponseresponse to injurysingle-cell RNA sequencingskillsstem cellssymposiumtranscriptome sequencingtranscriptomicstranslational therapeuticswound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
RESEARCH STRATEGY: The primary research objective of this proposal is to address how subtypes of
enteroendocrine cells change their activity (secretion) or state of differentiation in response to injury signals. A
better understanding of intestinal injury repair is critical to VA health priorities; the prevalence of inflammatory
bowel disease (IBD) has more than doubled among VA patients since 1998 and at least half of patients won’t
experience full mucosal healing with existing therapies. Hormones produced in intestinal enteroendocrine cells
(EEC) are altered in patients with IBD and can promote epithelial healing, but there is little understanding of
how EEC secretion is regulated during injury. The study of EECs has been limited because they are rare,
heterogenous, and not amenable to long-term primary culture with existing methods. To address this gap, we
have developed a new experimental system to culture EECs from primary colon samples in long-term
monolayers that supports all known EEC subtypes. We have discovered that subtypes of EEC are dynamically
altered with a simple experimental injury in vitro. The altered EECs increase the expression of factors that
promote intestinal healing. The goal of this proposal is to determine the cellular and transcriptional basis of
how subtypes of EEC respond to intestinal injury through altered activity or differentiation. Our Aims are to (1)
test the hypothesis that subtypes of EECs are adaptively reprogrammed by injury induced endoplasmic
reticulum (ER) stress, (2) test the hypothesis that microenvironmental injury signals reprogram EECs to
increase hormone secretion, and (3) define the transcriptional mechanisms of EEC reprogramming during
injury at single-cell resolution. The expected outcome of this work is to establish the new paradigm that
EECs undergo adaptive reprogramming during injury which will serve as the foundation for future independent
grant proposals. Additionally, we expect to discover novel secreted factors or altered states of differentiation in
EEC that would lead to new potential treatments for veterans suffering from intestinal or metabolic disorders.
CANDIDATE/ENVIRONMENT: Dr. Brian Muegge is a senior fellow in the Division of Endocrinology at
Washington University in St. Louis and the St. Louis VA Medical Center. He completed his M.D., Ph.D. training
at Washington University where he performed graduate studies in Dr. Jeffrey Gordon’s laboratory. Dr. Muegge
completed his residency in internal medicine at UCSF. He is conducting his fellowship research in the lab of his
primary mentor Dr. Thaddeus Stappenbeck and co-mentor Dr. Carlos Bernal-Mizrachi at Washington
University. Dr. Muegge has gained experience in intestinal stem cell culture and computational analysis of
transcriptional data. He has developed a novel culture system that allows him to model EEC development and
injury using primary cells. He now seeks to expand his expertise in new areas including lineage tracing, cell-
cell signaling, and single cell RNA sequencing prior to starting his independent research career.
CAREER DEVELOPMENT: This award will ensure that Dr. Muegge is able to establish a career as an
independent physician scientist in the VA health care system. He has developed a formal 5-year training plan
that will expand his scientific skills in intestinal development, in vitro models, and single cell transcriptomics, as
well as academic skills in scientific publishing, grant writing, and laboratory management. Dr. Muegge’s
training will be accomplished with experimental research, didactics, seminars, and national conferences. He
has assembled a scientific advisory committee with the requisite experience and expertise to monitor and
support his progress towards achieving his career goals. At the completion of the CDA-2, Dr. Muegge will be
equipped with skills in cutting edge technology (single cell transcriptomics, in vitro stem cell culture systems)
working in a unique area that sets him apart from others in the field (intestinal endocrine function during bowel
injury). He will be uniquely prepared to address fundamental questions that require knowledge of intestinal
biology, endocrinology, and computational biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enteroendocrine cell reprogramming during intestinal injury
-
批准号:10573165
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Brian David Muegge
-
依托单位:
Enteroendocrine cell reprogramming during intestinal injury
-
批准号:9888773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Brian David Muegge
-
依托单位:
Enteroendocrine cell plasticity during intestinal injury
-
批准号:9806688
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2019
-
负责人:Brian David Muegge
-
依托单位:
海外基金